EP3555115A4 - Novel compounds as anti-mycobacterials - Google Patents

Novel compounds as anti-mycobacterials Download PDF

Info

Publication number
EP3555115A4
EP3555115A4 EP17881453.9A EP17881453A EP3555115A4 EP 3555115 A4 EP3555115 A4 EP 3555115A4 EP 17881453 A EP17881453 A EP 17881453A EP 3555115 A4 EP3555115 A4 EP 3555115A4
Authority
EP
European Patent Office
Prior art keywords
mycobacterials
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17881453.9A
Other languages
German (de)
French (fr)
Other versions
EP3555115A1 (en
Inventor
Richard J. Payne
Warwick John BRITTON
Anh Tran
Wendy TRAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016905229A external-priority patent/AU2016905229A0/en
Application filed by University of Sydney filed Critical University of Sydney
Publication of EP3555115A1 publication Critical patent/EP3555115A1/en
Publication of EP3555115A4 publication Critical patent/EP3555115A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP17881453.9A 2016-12-16 2017-12-15 Novel compounds as anti-mycobacterials Withdrawn EP3555115A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016905229A AU2016905229A0 (en) 2016-12-16 Novel compounds as anti-mycobacterials
PCT/AU2017/051394 WO2018107236A1 (en) 2016-12-16 2017-12-15 Novel compounds as anti-mycobacterials

Publications (2)

Publication Number Publication Date
EP3555115A1 EP3555115A1 (en) 2019-10-23
EP3555115A4 true EP3555115A4 (en) 2020-08-05

Family

ID=62557690

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17881453.9A Withdrawn EP3555115A4 (en) 2016-12-16 2017-12-15 Novel compounds as anti-mycobacterials

Country Status (4)

Country Link
EP (1) EP3555115A4 (en)
CN (1) CN110300759A (en)
AU (1) AU2017377671A1 (en)
WO (1) WO2018107236A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755076A (en) * 2016-04-11 2016-07-13 中国医学科学院医药生物技术研究所 Method for synthesizing and obtaining SANSANMYCIN structural analogue by utilizing mutation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755076A (en) * 2016-04-11 2016-07-13 中国医学科学院医药生物技术研究所 Method for synthesizing and obtaining SANSANMYCIN structural analogue by utilizing mutation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018107236A1 *
YUANYUAN SHI ET AL: "Improving the N-terminal diversity of sansanmycin through mutasynthesis", MICROBIAL CELL FACTORIES, vol. 15, no. 1, 6 May 2016 (2016-05-06), XP055708506, DOI: 10.1186/s12934-016-0471-1 *

Also Published As

Publication number Publication date
WO2018107236A1 (en) 2018-06-21
CN110300759A (en) 2019-10-01
AU2017377671A1 (en) 2019-07-11
EP3555115A1 (en) 2019-10-23

Similar Documents

Publication Publication Date Title
EP3720430A4 (en) Benzocarbonyl compounds
EP3691623A4 (en) Benzosulfonyl compounds
EP3286169A4 (en) Novel compounds
EP3564232A4 (en) Bmp-signal-inhibiting compound
EP3196187A4 (en) Novel compound
EP3325449A4 (en) Compounds
EP3224246A4 (en) 4-oxoquinoline compounds
EP3099695A4 (en) Compounds
EP3099694A4 (en) Compounds
EP3172208A4 (en) Compounds
EP3148975A4 (en) Novel compounds
EP3214086A4 (en) Substituted dihydropyrrolopyrazole compound
EP3464336A4 (en) Compounds
EP3509589A4 (en) Novel uses
EP3533799A4 (en) Compound
EP3110792A4 (en) Aminocarbonylcarbamate compounds
EP3402829A4 (en) Silicone-compatible compounds
EP3573975A4 (en) Compounds
EP3573956A4 (en) Compounds
EP3573976A4 (en) Compounds
EP3321309A4 (en) Compound
EP3148985A4 (en) Novel compounds
EP3480228A4 (en) Composition
EP3152190A4 (en) 18-20 member bi-polycyclic compounds
EP3378863A4 (en) Pyranodipyridine compound

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190709

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/00 20060101ALI20200702BHEP

Ipc: C07K 5/02 20060101AFI20200702BHEP

Ipc: C07K 5/037 20060101ALI20200702BHEP

Ipc: A61K 38/07 20060101ALI20200702BHEP

Ipc: A61P 31/06 20060101ALI20200702BHEP

Ipc: A61K 38/04 20060101ALI20200702BHEP

Ipc: A61P 31/04 20060101ALI20200702BHEP

Ipc: A61P 31/08 20060101ALI20200702BHEP

Ipc: A61P 11/00 20060101ALI20200702BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210209